| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J. Biol. Chem., Vol. 259, Issue 6, 3568-3577, Mar, 1984
T Katada, GM Bokoch, JK Northup, M Ui and AG Gilman
Treatment of membranes with islet activating protein (IAP), a toxin from Bordetella pertussis, results in abolition of GTP-dependent, receptor-mediated inhibition of adenylate cyclase. This appears to result from IAP-catalyzed ADP-ribosylation of a 41,000-Da membrane- bound protein. A protein with 41,000- and 35,000-Da subunits has been purified from rabbit liver membranes as the predominant substrate for IAP. This protein has now been shown to be capable of regulating membrane-bound adenylate cyclase activity of human platelets under various conditions. The characteristics of the actions of the IAP substrate are as follows. 1) Purified 41,000/35,000-Da dimer is capable of restoring the inhibitory effects of guanine nucleotides and the alpha 2-adrenergic agonist, epinephrine, on the adenylate cyclase activity of IAP-treated membranes. 2) The subunits of the dimer dissociate in the presence of guanine nucleotide analogs or A1(3+), Mg2+, and F-. The 41,000-Da subunit has a high affinity binding site for guanine nucleotides. 3) The resolved 35,000-Da subunit of the dimer mimics guanine nucleotide- and epinephrine-induced inhibition of adenylate cyclase. 4) The resolved (unliganded) 41,000-Da subunit stimulates adenylate cyclase activity and relieves guanine nucleotide- +/- epinephrine-induced inhibition of the enzyme. In contrast, the GTP gamma S-bound form of the 41,000-Da subunit inhibits adenylate cyclase activity, although with lower apparent affinity than does the 35,000-Da subunit. 5) The 35,000-Da subunit increases the rate of deactivation of Gs, the stimulatory regulatory protein of adenylate cyclase. In contrast, the 41,000-Da subunit can interact with Gs and inhibit its deactivation. These data strongly suggest that the IAP substrate is another dimeric, guanine nucleotide-binding regulatory protein and that it is responsible for inhibitory modulation of adenylate cyclase activity.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  S. D. Carvalho-Bianco, B. W. Kim, J. X. Zhang, J. W. Harney, R. S. Ribeiro, B. Gereben, A. C. Bianco, U. Mende, and P. R. Larsen Chronic Cardiac-Specific Thyrotoxicosis Increases Myocardial {beta}-Adrenergic Responsiveness Mol. Endocrinol., July 1, 2004; 18(7): 1840 - 1849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. El-Armouche, O. Zolk, T. Rau, and T. Eschenhagen Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure Cardiovasc Res, December 1, 2003; 60(3): 478 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. ZHAO, J. Z. YEH, and T. NARAHASHI Post-Stroke Dementia: Nootropic Drug Modulation of Neuronal Nicotinic Acetylcholine Receptors Ann. N.Y. Acad. Sci., June 1, 2001; 939(1): 179 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Chen, K. Spicher, M. Jiang, L. Birnbaumer, and G. T. Wetzel Lack of muscarinic regulation of Ca2+ channels in Gi2{alpha} gene knockout mouse hearts Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H1989 - H1995. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhao, A. Kuryatov, J. M. Lindstrom, J. Z. Yeh, and T. Narahashi Nootropic Drug Modulation of Neuronal Nicotinic Acetylcholine Receptors in Rat Cortical Neurons Mol. Pharmacol., April 1, 2001; 59(4): 674 - 683. [Abstract] [Full Text]
|
|
|
|
 |
|
 K.-C. Tang and D. M. Lovinger Role of Pertussis Toxin-Sensitive G-Proteins in Synaptic Transmission and Plasticity at Corticostriatal Synapses J Neurophysiol, January 1, 2000; 83(1): 60 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Sarvazyan, A. E. Remmers, and R. R. Neubig Determinants of Gi1alpha and beta gamma Binding. MEASURING HIGH AFFINITY INTERACTIONS IN A LIPID ENVIRONMENT USING FLOW CYTOMETRY J. Biol. Chem., April 3, 1998; 273(14): 7934 - 7940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Taussig, J. Iniguez-Lluhi, and A. Gilman Inhibition of adenylyl cyclase by Gi alpha Science, July 9, 1993; 261(5118): 218 - 221. [Abstract] [PDF]
|
|
|
|
|
|
M. Simon, M. Strathmann, and N Gautam Diversity of G proteins in signal transduction Science, May 10, 1991; 252(5007): 802 - 808. [Abstract] [PDF]
|
|
|
|
|
|
P. Majerus, T. Connolly, H Deckmyn, T. Ross, T. Bross, H Ishii, V. Bansal, and D. Wilson The metabolism of phosphoinositide-derived messenger molecules Science, December 19, 1986; 234(4783): 1519 - 1526. [Abstract] [PDF]
|
|
|
|
|
|
S. Steinberg, E. Drugge, J. Bilezikian, and R. Robinson Acquisition by innervated cardiac myocytes of a pertussis toxin-specific regulatory protein linked to the alpha 1-receptor Science, October 11, 1985; 230(4722): 186 - 188. [Abstract] [PDF]
|
|
|
|
|
|
B. Harris, J. Robishaw, S. Mumby, and A. Gilman Molecular cloning of complementary DNA for the alpha subunit of the G protein that stimulates adenylate cyclase Science, September 20, 1985; 229(4719): 1274 - 1277. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |
